Agree maxter, strengthening volume leading into full analysis (Ann Q1).
The breastcancer 1b result (imminent) will be comprehensive (as full analysis is).
Two cohorts (one extended) with varying dosage levels of the Ptx-200 compound.
Between and ad hoc reviews should allow insight to any confound factor(s), correlation and of course causation.
Phase 1b results will finalise phase 2a design and commencement.
The pips you have referred to are possible profit taking and/or other individual’s project needs.
I say that simply because of the above, that is; hard to sell at these levels when within weeks a better decision can be made (IMO).
Luck to holders and welcoming new alike.
PTX Price at posting:
7.4¢ Sentiment: Buy Disclosure: Held
